To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis

Multi-Center, Double-Blind, Randomized, Vehicle-controlled, Parallel-Group Study Comparing NYC-0462 Ointment To a Vehicle Control

The aim of this trial is to assess the efficacy of NYC-0462 Ointment in the Treatment of Plaque Psoriasis.Treatment medication will be administered as follows: A thin layer of study product will be applied to the affected skin, excluding the face, once daily, at approximately the same time daily.

Inclusion Criteria:

• Diagnosis of stable, symptomatic plaque psoriasis
• Good health with the exception of psoriasis
• % BSA and plaque elevation requirements

Exclusion Criteria:

• Subjects who are pregnant, nursing or planning a pregnancy within the study participation period.
• Subjects who have any systemic or dermatological disorders with the exception of psoriasis